Med Cause -

Schedule of LNT cells delivery of CRISPR-Cas9 nanoparticles for KRAS-mutant NSCLC treatment. Credit: Science Advances (2024). DOI: 10.1126/sciadv.adk8264

A team of medical researchers at Zhejiang University, in China, has developed a way to use cryo-shocked tumor cells to fight lung cancer. In their study, published in the journal Science Advances, the group used fast liquid nitrogen treatment to modify tumor cells to carry gene-editing tools to fight tumors in mouse models.

As noted by the researchers, CRISPR-mediated genome editing tools and techniques hold great promise for treating cancer. However, problems with tumor targeting and off-target side effects hamper their effectiveness. For this new research, the team found a way to improve targeting by converting tumor cells into carriers for the gene editing tools.
The work involved cryo-shocking tumor cells extracted from a patient, which involved rapid freezing using liquid nitrogen. Such freezing removed their pathogenicity while preserving their structure, and more importantly, their surface receptor functions. After freezing, the CRISPR-Cas9 system was loaded into the cryo-shocked tumor cell, which made its way to the tumor, where it was ablated.
The team tested their approach by collecting tumor samples from lung cancer mouse models, cryo-shocking the samples, loading them with the CRISPR-Cas9 system and then injecting them back into the mice. The treated tumor cells made their way to the tumor as hoped, where they released the CRISPR-Cas9 system, which in turn knocked down cyclin-dependent kinase 4, resulting in tumor cell death.
In comparing the approach to simply injecting the CRISPR-Cas9 system into tumors, the research team found that the newer approach offered greater lethality. The improvement, they found, was due to greater accuracy in targeting. The deactivated tumor cells were drawn to the tumor, where they bonded with the active tumor cells via cell receptors, giving the gene editing system direct access to target cells. The approach also prevented the gene editing system from working on noncancerous cells.
The research team noted also that freezing cancer cells using liquid nitrogen allowed the cells to retain their antigens, which they suggest could prove useful in developing a vaccine as part of cancer treatment.

More information:
Feng Liu et al, Cryo-shocked tumor cells deliver CRISPR-Cas9 for lung cancer regression by synthetic lethality, Science Advances (2024). DOI: 10.1126/sciadv.adk8264

© 2024 Science X Network

Using cryo-shocked tumor cells to fight lung cancer (2024, April 1)
retrieved 1 April 2024

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

Share this article
Shareable URL
Prev Post
Next Post
Leave a Reply

Your email address will not be published. Required fields are marked *

Read next
Rendering of interface in the mutant EGFR studied that was shown to be critical for EGFR-driven tumor growth.…
Mailed at-home self-sampling for human papillomavirus (HPV) testing increases cervical cancer screening…
Credit: CC0 Public Domain Cancer is the leading cause of disease-related death in children in most developed…
Combined macroautophagy and CD95 death receptor signaling facilitate additional tumor cell killing by GZ17-6.02.…
Need Help?